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cord care: EN-BIRTH multi-country study
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Ahmed Ehsanur Rahman1, Patricia S. Coffey8, Barbara Rawlins9, Louise T. Day2, Joy E. Lawn2†, Shams Arifeen1† and
EN-BIRTH Study GroupAbstract
Background: Umbilical cord hygiene prevents sepsis, a leading cause of neonatal mortality. The World Health
Organisation (WHO) recommends 7.1% chlorhexidine digluconate (CHX) application to the umbilicus after home
birth in high mortality contexts. In Bangladesh and Nepal, national policies recommend CHX use for all facility
births. Population-based household surveys include optional questions on CHX use, but indicator validation studies
are lacking. ‘Every Newborn Birth Indicators Research Tracking in Hospitals’ (EN-BIRTH) was an observational study
assessing measurement validity for maternal and newborn indicators. This paper reports results regarding CHX.
Methods: The EN-BIRTH study (July 2017–July 2018) included three public hospitals in Bangladesh and Nepal
where CHX cord application is routine. Clinical-observers collected tablet-based, timestamped data regarding cord
care during admission to labour and delivery wards as the gold standard to assess accuracy of women’s report at
exit survey, and of routine-register data. We calculated validity ratios and individual validation metrics; analysed
coverage, quality and measurement gaps. We conducted qualitative interviews to assess barriers and enablers to
routine register-recording.
Results: Umbilical cord care was observed for 12,379 live births. Observer-assessed CHX coverage was very high at
89.3–99.4% in all 3 hospitals, although slightly lower after caesarean births in Azimpur (86.8%), Bangladesh. Exit
survey-reported coverage (0.4–45.9%) underestimated the observed coverage with substantial “don’t know”
responses (55.5–79.4%). Survey-reported validity ratios were all poor (0.01 to 0.38). Register-recorded coverage in the
specific column in Bangladesh was underestimated by 0.2% in Kushtia but overestimated by 9.0% in Azimpur.
Register-recorded validity ratios were good (0.9 to 1.1) in Bangladesh, and poor (0.8) in Nepal. The non-specific
register column in Pokhara, Nepal substantially underestimated coverage (20.7%).
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Conclusions: Exit survey-report highly underestimated observed CHX coverage in all three hospitals. Routine
register-recorded coverage was closer to observer-assessed coverage than survey reports in all hospitals, including
for caesarean births, and was more accurately captured in hospitals with a specific register column. Inclusion of
CHX cord care into registers, and tallied into health management information system platforms, is justified in
countries with national policies for facility-based use, but requires implementation research to assess register design
and data flow within health information systems.
Keywords: Birth, Newborn, Coverage, Validity, Survey, Hospital records, Health management systems, 7.1%





































What is known and what is new about this study
• Application of 7.1% chlorhexidine digluconate for umbilical cord care
(CHX) is recommended by the World Health Organisation (WHO) for
home births in high newborn mortality settings, and is being scaled up
in many countries, including for hospital births.
• There are limited data tracking coverage at national or global levels.
Although the Demographic and Health Surveys’ (DHS) additional
modules have optional questions, there is little country uptake and
these are not yet validated.
• EN-BIRTH is the first multi-country observational study to assess valid-
ity of the use of CHX measurement (n = 12,379 observed newborns)
compared to women’s report on exit survey and routine register-
recording.
Survey – what did we find and what does it mean?
• We used the same survey questions as the DHS optional newborn
module.
• We found high observed coverage (96.6%) but also high (71.5%)
“don’t know” replies from women reporting on application of CHX to
their newborn’s umbilical cord.
• Survey-reported coverage (11.3%) vastly underestimated observed
coverage (96.6%) in hospitals and was extremely inaccurate.
Register – what did we find and what does it mean?
• Registers designed with a specific column more accurately recorded the
high coverage of CHX application than those with non-specific columns.
• The same register design performed differently in two separate
facilities, and CHX coverage was slightly overestimated (9.0%) in one.
• Qualitative data highlighted opportunities to improve register design,
completion and use, especially training and supervision.
Gap analysis for quality of care and of measurement
• Almost all newborns observed received CHX, hence the coverage
gap was small, except after caesarean birth in one facility.
• Quality of care in terms of timing revealed that most newborns
(92.2%) received CHX within 1 h of birth.
• Further research is needed to assess the optimal sequencing of
immediate newborn care interventions to avoid separation of women
and newborns, promote early breastfeeding, and ensure that CHX
application enhances and does not delay time sensitive practices.
What next and research gaps
• CHX has become a part of immediate newborn care policy in many
countries, including for facility births.
• For institutional births, well-designed routine registers have higher ac-
curacy than women’s exit survey-reports, but research is required on de-
sign and data flow in health management systems.
• Given the poor performance of survey-reported data for facility-based
CHX use, further survey validation research should focus on home births,
or postnatal application by women to explore how best to measure





Globally, almost half of under-five mortality occurs during
the first 4 weeks after birth, the neonatal period [1, 2].Infection is a leading cause of neonatal mortality, particu-
larly in high-mortality contexts in low to middle-income
countries (LMICs) [3, 4]. The newborn umbilical stump is
an important entry point for sepsis and systemic infections
[5, 6]. Research has shown that the application of 7.1%
chlorhexidine digluconate, a broad-spectrum antiseptic, to
the umbilical cord (CHX) can reduce mortality, especially
if applied on the first day of life as per World Health
Organization (WHO) guidelines [7]. The highest gain is
for very low birthweight neonates, where a dose response
by birthweight is evident, and newborns benefit from early
application [8–10]. Beyond day one, CHX application re-
duces the risk of local infection to the cord stump (from
56 to 27%) and may also reduce later mortality risk [11].
Hence this low-cost intervention could contribute to re-
ducing the burden of mortality due to neonatal sepsis in
the first week of life [8, 12–14].
The WHO recommends clean, dry cord care for all
newborns and daily CHX application to the umbilical
stump for the first week of life for homebirths in high
neonatal mortality settings (> 30 deaths/1000 livebirths) [6,
15]. These recommendations reflect the evidence available
at the time, which included randomised trials mainly
conducted in high-mortality homebirth settings in South
Asia, including Nepal and Bangladesh [6]. These guidelines
noted the potential for CHX application to lower or replace
traditional practices, including application of harmful sub-
stances such as cow dung [6]. There are now two African
studies of umbilical cord cleansing for home births, but
these did not report significant mortality benefits [16, 17].
Despite many concerns regarding hospital acquired
infections [18, 19], no randomised trial has rigorously
assessed mortality effect for facility births to date,
although there is an ongoing randomised controlled trial
testing a single application of 4% chlorhexidine in
Uganda [20]. Analysis from 3223 facility births in
Bangladesh and Nepal observed significant decreases in
mortality in newborns who received CHX [21]. At least
15 countries have implemented a national policy for use
of CHX; most, including Bangladesh and Nepal, have a
national policy for universal CHX coverage for all births,
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terventions is needed to drive progress to achieve Sus-
tainable Development Goal 3.2, ending preventable
neonatal mortality. Currently, umbilical cord care cover-
age is measured by population-based household survey
programmes such as the Demographic and Health Surveys
(DHS) Program and Multiple Indicator Cluster Surveys
(MICS) typically conducted every 3–5 years (Additional file
1). MICS includes a standard question on cord care prac-
tices [23]; however, in DHS this is included in an optional
add-on newborn care module with the question: “Was
chlorhexidine applied to the stump at any time?” [24] (Add-
itional file 1). Household surveys have many strengths, in-
cluding a nationally representative sample. However,
previous validity research findings for indicators of practices
and interventions around the time of birth are mixed. At a
minimum, women can only report on clinical interventions
they have either discussed with health providers, directly
experienced during a state of regular consciousness, or have
witnessed [25–30]. Only one previous research study has
tested validity of survey CHX measurement in Nigeria, al-
though this had a small sample size [25].
Where CHX application is implemented in facilities,
the opportunity exists to track coverage using facility
register data for routine health management information
systems (HMIS). These data have the advantage of being
aggregated and available for use in decision making on a
far more frequent basis than household survey data, and
thus have the potential to regularly inform quality
improvement efforts at subnational levels of the health
system. Data accuracy must be trusted to promote use for
planning, management, resource allocation and quality
monitoring [31]. No previous research has assessed validity
of register-recorded measures for CHX coverage [7].
The Every Newborn Action Plan, supported by all
United Nations member states and > 80 development
partners, includes an ambitious Measurement Improvement
Roadmap [32, 33] with an urgent focus on validating
indicators for care and outcomes around the time of birth.
As part of this roadmap, Every Newborn– Birth Indicators
Research Tracking in Hospitals (EN-BIRTH) study, was a
mixed-methods observational study of > 23,000 hospital
births in three countries (Tanzania, Bangladesh and Nepal)
and aimed to validate selected newborn and maternal indi-
cators for routine facility-based tracking of coverage, quality
of care, and outcomes [34, 35]. At the time of study design
Tanzania did not have a policy for CHX; therefore, this





This paper is part of a supplement based on the EN-
BIRTH multi-country study, ‘Informing measurement of
coverage and quality of maternal and newborn care’, andfocuses on application of CHX, with three main
objectives:
1. Assess NUMERATOR accuracy/validity of
measurement for a coverage indicator of single
application 7.1% chlorhexidine to the umbilical cord
stump via exit-survey of women’s report and
routine labour ward register data, compared to
observation (gold standard).
2. Analyse GAPS in coverage and quality of care,
and measurement for application of 7.1% CHX
to the umbilical cord stump, including observation
data to assess right time, right substance applied
and experience of care (assessed via survey-report
regarding recall of communication of care).
3. Evaluate BARRIERS AND ENABLERS to
routine labour ward register-recording for CHX
through qualitative interviews regarding register
design, completion and use.
Methods
EN-BIRTH was an observational mixed-methods study and
compared data from clinical observers about CHX applica-
tion (gold standard) to women’s exit-interview survey re-
ported coverage (Additional file 2) and routine register-
recorded coverage (Fig. 1). Trained clinical nurses observed
participants 24 h per day throughout the woman’s admis-
sion to labour and delivery ward. They recorded data on
care and outcomes, including application of CHX to the
umbilical cord stump (Fig. 1). All data collectors were given
training to recognise the correct product for local use. Data
were collected using a custom-built android tablet-based
software application that included timestamps for observa-
tion data (July 2017–July 2018) in three public hospitals
providing comprehensive emergency obstetric and new-
born care (CEmONC) and application of CHX: Bangladesh
(Maternal and Child Health Training Institute (MCHTI),
Azimpur, and Kushtia General Hospital), and Nepal
(Pokhara Academy Health Sciences) (Additional file 3). Par-
ticipants were consenting women admitted in labour in the
three study sites (Additional file 4). Metadata definitions for
the CHX indicator are also shown (Additional file 4). All
statistical analyses were undertaken using Stata 15.0 (Stata
Corporation, College Station, TX, USA). Results were re-
ported in accordance with STROBE statement checklists
for cross-sectional studies (Additional file 5). Detailed infor-
mation regarding the research protocol, methods, and ana-
lysis has been published separately [34, 35].
Labour ward registers
All three study hospitals used pre-printed routine labour
ward registers. The register design in Bangladesh chan-
ged to a standardised national labour ward register dur-















































f1:1 Fig. 1 Chlorhexidine validation design, EN-BIRTH study. EN-BIRTH: Every Newborn Birth Indicators Research Tracking in Hospitals; HMIS: Health
f1:2 Management Information Systems; DHIS2: District Health Information Software 2; DHS: Demographic and Health Surveys; MICS: Multiple Indicator
f1:3 Cluster Surveys. 7.1% Chlorhexidine solution applied to the umbilicus
f1:4
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tion labelled, 7.1% Chlorohexidine used on the umbilical
cord. A blank box was provided where staff were
instructed to tick for ‘given’ and leave blank for ‘not given’.
In Pokhara, Nepal, CHX application is recorded in a non-
specific column labelled “general remarks” and health
workers were instructed to document ‘CHX is given’ or
leave blank if ‘not given’. Only results from revised regis-
ters for the Bangladesh sites are presented in this paper.
Methods and analysis by objective
Objective 1: numerator validation
We compared exit survey-reported and register-recorded
coverage to observer-assessed coverage of CHX and strati-
fied by hospital and mode of birth: vaginal births and cae-
sarean births. Percentages of “don’t know” replies for exit
survey questions, and ‘not recorded or not readable’ for
register-recorded data were also calculated. In line with
how DHS/MICS typically analyse ‘yes/no/don’t know’
questions, we compared survey-reported results with
“don’t know” considered as “no” against “don’t know” ex-
cluded. Similarly, for register-recorded coverage, we com-
pared results with “not recorded” considered as “no” and
also excluded.We calculated absolute differences between measured
coverage (survey or register) and observed coverage to
understand under- or over-estimation at the population
level. Using two-way tables, we calculated individual-level
validity statistics: sensitivity, specificity, and percent agree-
ment (true positive + true negative / total) of register-
recorded and survey-reported CHX coverage to observed
coverage. Area under the curve, inflation factor, positive
predictive value, and negative predictive value were also
calculated. We report results where column totals were ≥
10 in the two-by-two tables. Pooled results for validity
analyses were calculated using random effects meta-
analysis, presented with i2, τ2, and heterogeneity statistic
(Q). We calculated “validity ratios” (against gold standard),
heat-mapping results using standard data quality review
cut-offs (over/underestimate by 0 to 5%, by 6–10%, by
11–15%, by 16–20 and > 20%) [36]. All calculations in-
cluded 95% confidence intervals where appropriate.
Objective 2: gap analysis for quality of care in relation to
measurement
We analysed four gaps for CHX use in hospitals: 1)
Coverage gap between the target population (all live
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to have anything applied to the cord and those correctly
having CHX applied. Current WHO guidelines suggest
CHX application within the first day, however ‘correct’
time was taken to be within 1 hour of birth, because
observations were restricted to the labour and delivery
ward in this study. 3) Measurement gap for register
records (observed and register-recorded coverage gap).
4) Measurement gap for survey reports (observed and
survey-reported coverage of any cord cleansing after
birth).
Objective 3: barriers and enablers to data collection
As part of the EN-BIRTH study, qualitative interviews
were conducted to understand the barriers and enablers
for routine register-recording of interventions around
birth. Qualitative data were collected from a purposive
sample of health workers (nurses/midwives and doctors)
and EN-BIRTH study data collectors. Interviews were
recorded, transcribed, translated and NVIVO (QSR
International Pty Ltd. Version 12) software was used for
data management.
Detailed qualitative methods and overall results are
available in an associated paper [37]. Qualitative analysis
began with identifying emerging themes based on the
Performance of Routine Information System Management
(PRISM) conceptual framework [38]. This paper specifically
presents themes relating to the recording of umbilical
application of CHX.
Results
Sample description and selection
Among 12,379 live births observed for CHX use on
labour ward in Bangladesh and Nepal, 10,772 livebirths
(87.0%) were included for register extraction (Fig. 2).
95.3% of women completed an exit survey (12,097
women interviewed out of the possible 12,692 women
observed) which correspond to 95.5% livebirths (11,827
live births out of the possible 12,379 live births
observed).
Birth outcomes and background characteristics are
shown in Table 1. Almost three-quarters (72.8%) of
births in Azimpur were via caesarean section compared
to 40.3% in Kushtia and 15.5% in Nepal. Overall, more
than 60% of the women were aged between 20 and 29
years, and 2.7% were < 18 years. Completion of second-
ary education was lowest in Kushtia (Bangladesh, 36.1%)
and highest in Pokhara (Nepal, 61.2%). Approximately
13.4% of newborns were < 2500 grammes across the
three facilities.
Objective 1: numerator validation
To calculate coverage we used the recommend
denominator of all live births. In this analyses weincluded the following denominators; observer-assessed
(n = 12,379 live births), register-recorded (n = 11,002 live
births), and exit survey-reported (n = 11,827 livebirths).
Observer-assessed coverage of CHX application within 1
hour of birth was high in all three hospitals for both va-
ginal births (97.7, 95% CI 94.4–99.6%) and caesarean
sections (97.1, 95% CI 94.4–99.6%) (Fig. 3).
Exit-interview survey-reported validation
CHX coverage was consistently underestimated by
survey compared with gold standard in all three sites for
vaginal births and caesarean births (Fig. 3). Responses
yielded high “don’t know” replies for both vaginal births
and caesarean section (68.5, 95% CI 47.9–85.9% / 76.4,
95% CI 66.6–85.0% respectively). Percent agreement was
low (18.1, 95% CI 5.5–35.9%), and analysis criteria (> 10
column count) was only met for one facility (Table 2).
Survey-reported timing of CHX (within 1 hour of birth)
showed high specificity 94.7% (95% CI 74.3–100.0%) but
low sensitivity 6.7% (95%CI 0.0–23.9%) in all facilities
(Additional file 6), including “don’t knows”. Most
women (56.1% in Kushtia to 79.4% in Pokhara) reported
that the health worker did not inform them or they do
not know if anything was applied to their newborns
umbilical cord (Additional file 7).
Register-recorded validation
Register-recorded CHX application coverage was variable
between the three hospital registers. Most accurate was
the register-recorded coverage in Kushtia (Bangladesh),
underestimating by only 0.2% (Table 3). This identical
register captured CHX in a specific column and overesti-
mated coverage by 9.0% in Azimpur (Bangladesh). The
least accurate register-recorded coverage was from the
non-specific column in Pokhara, underestimating cover-
age by 20.7% (Fig. 4). Register performance to measure
CHX application was consistently better for vaginal than
caesarean births (Table 3). In Pokhara, register-recorded
coverage was underestimated by 15.1% for vaginal births
(99.4–84.3%) and 60.4% for caesareans (99.2–39.0%). Per-
cent agreement was high especially for vaginal births
(83.9%) and increased when “don’t know” responses are
excluded (98.9%), although all facilities had a column
count < 10 (Additional file 8). In Bangladesh, register in-
structions dictated that the column was left blank when
CHX was not applied, which was problematic for analysis
because there was no true measure of ‘not given’.
Comparison of heat-mapped validity ratios for exit-
survey or register-recorded measures compared with
observer-assessed suggested that register data for CHX
was more accurate (ratio 0.94) than women’s report (ra-
tio 0.12). It was categorised as ‘good’ for vaginal birth
and caesareans (ratios ~ 1.00) in both Bangladesh hospi-
































f2:1 Fig. 2 Flow diagram for cord Chlorhexidine application in Bangladesh and Nepal, EN-BIRTH study. 7.1% Chlorhexidine solution applied to the umbilicus
f2:2
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ratios for survey-reported results were categorised as
‘poor’ (ratio range 0.01 to 0.38) in all facilities (Fig. 5).
Objective 2: gaps analysis for coverage, quality of care in
relation to measurement
Almost all newborns in these facilities were observed to
receive CHX. The coverage gap was very small for the
target population of all livebirths (Fig. 6). Within these
facilities, there was close observed alignment between
application of anything and CHX to the cord, however
this leads to a measurement gap in survey report where
women were more able to report that something was
applied (17.8%), rather than CHX (12.3%) (Additional
file 9). Quality of care gap analysis showed timing
distribution (less than 1 h of birth) was similar among
each facility and by mode of birth. Survey reported“don’t knows” were higher in Azimpur and Pokhara
considering all modes of birth.
Objective 3: barriers and enablers to data collection
These findings were specific to recording practices for
CHX, but more detailed qualitative results are available
in a supporting paper [37]. Respondents in all hospitals
talked of the complexity of multiple registers (both
formal and informal register books) to record
interventions around birth, including CHX (Fig. 4).
In Bangladesh the revised register design was an
enabler:
“Previously we did not document the care of chlor-
hexidine in registers as it did not (have) space to
write. Now this new register has a specific column
















t1:1 Table 1 CharacteristicsQ6 of women observed in labourQ7 and delivery wards, EN-BIRTH study EN-BIRTH study (n = 12,837)
t1:2 Bangladesh Bangladesh Nepal All sites
t1:3 Azimpur Tertiary Kushtia District Pokhara Regional
t1:4 n (%) n (%) n (%) n (%)
t1:5 A). Total Newborns who were observed (Denominator) 2936 2459 7442 12837
t1:6 Birth outcome - live birth 2896 (98·6) 2308 (93·9) 7175 (96·4) 12379(96.4)
t1:7 Newborn condition at L&D discharge
t1:8 Alive 2895(98.6) 2302(93.6) 7171(96.4) 12368(96.3)
t1:9 Stillbirths 11(0.4) 74(3) 126(1.7) 211(1.6)
t1:10 Neonatal death 1(0) 6(0.2) 4(0.1) 11(0.1)
t1:11 Baby not delivered 2(0.1) 2(0.1) 6(0.1) 10(0.1)
t1:12 Birth outcome not observed 27(0.9) 75(3.1) 135(1.8) 237(1.8)
t1:13 Mode of birth
t1:14 Normal vaginal birth 767(26.4) 1364(56.6) 5840(79.2) 7971(62.8)
t1:15 Vaginal breech/ Vacuum/ Forceps 1(0) 0(0) 349(4.7) 350(2.8)
t1:16 Caesarean Section 2119(72.8) 972(40.3) 1140(15.5) 4231(33.3)
t1:17 Not observed 23(0.8) 76(3.2) 41(0.6) 140(1.1)
t1:18 Birthweight of baby < 2500 g 353(11.9) 473(19.3) 897(12.1) 1723(13.4)
t1:19 Sex Female/Girl baby 1427(49) 1128(46.8) 3335(45.3) 5890(46.4)
t1:20 B). Total women who were observed 2910 2412 7370 12,692
t1:21 Women’s Agea
t1:22 < 18 years 25(0.9) 3(0.1) 311(4.2) 339(2.7)
t1:23 18–19 years 475(16.3) 197(8.2) 817(11.1) 1489(11.7)
t1:24 20–24 years 1158(39.8) 954(39.6) 3080(41.8) 5192(40.9)
t1:25 25–29 years 867(29.8) 736(30.5) 2114(28.7) 3717(29.3)
t1:26 30–34 years 297(10.2) 373(15.5) 827(11.2) 1497(11.8)
t1:27 35+ years 88(3) 149(6.2) 221(3) 458(3.6)
t1:28 Mean (SD) 23.9(4.5) 24.9(4.9) 24.2(4.7) 24.3(4.7)
t1:29 Women’s educationa
t1:30 No education 39(1.3) 77(3.2) 268(3.6) 384(3)
t1:31 Primary incomplete 111(3.8) 127(5.3) 252(3.4) 490(3.9)
t1:32 Primary complete 339(11.6) 347(14.4) 302(4.1) 988(7.8)
t1:33 Secondary incomplete 985(33.8) 954(39.6) 1637(22.2) 3576(28.2)
t1:34 Secondary complete or higher 1273(43.7) 870(36.1) 4509(61.2) 6652(52.4)
t1:35 Missing 163(5.6) 37(1.5) 402(5.5) 602(4.7)
t1:36 Mean (SD) 8.8(4.1) 8.2(3.6) 9.6(4.4) 9.1(4.2)
t1:37 Data were collected from awomen’s registration and bsurvey report
Zaman et al. BMC Pregnancy and Childbirth _#####################_ Page 7 of 16applied or not.” (Health worker, Azimpur MCHTI,
Bangladesh)
Most respondents from Bangladesh and some in Nepal
agreed that it is useful to have a specific column on
CHX in the register:
“Now, more information is added to the delivery
register than before. For example, informationrelated chlorhexidine was not included before.”
(Health worker, Kushtia, Bangladesh)
In Bangladesh, respondents from Kushtia reported
that they were not confident to record in the new
register due to a lack of formal training. This was in
contrast to Azimpur, where more formal supervision













































f3:1 Fig. 3 Coverage rates for Chlorhexidine cord application measured by observation, register and exit-survey, EN-BIRTH study (n = 12,379). Register-
f3:2 recorded (n = 11,002 livebirths) and exit survey-reported (n = 11,827 livebirths) in the EN-BIRTH Study, split by three hospitals. BD: Bangladesh; NP:
f3:3 Nepal. 7.1% Chlorhexidine solution applied to the umbilicus
f3:4
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hospital. The in-charge has told us verbally how
to fill up the register and write information in
other informal books.” (Health Worker, Azimpur,
Bangladesh)
Discussion
EN-BIRTH is the largest observational study to assess
validity of coverage measurement for CHX application
through women’s exit-interview survey to date, and the
first to assess validity of routine hospital registers. Our
multi-site, multi-country design enabled comparisons
between and within countries. The large sample size
enabled the first assessment of how caesarean section
affects CHX coverage measurement.
For household surveys, CHX coverage questions are
already included in the optional newborn module of
DHS. Our data collectors also used the visual prompt (a
picture showing CHX bottle) to the mother in line with
survey procedures used by DHS for this question.
Survey-reported validation results showed substantial
underestimation of coverage, especially after caesareansection. “Don’t know” responses exceeded 50% regarding
if any substance, or CHX specifically, was applied to the
cord. These findings are consistent with other research
that shows low accuracy of survey-report for clinical in-
terventions around the time of birth [25, 28–30].
A recent study from Nigeria showed much lower
“don’t know” replies (5%), and high sensitivity and
specificity [25]. Nigeria uses a multi-day regime in con-
trast to Bangladesh and Nepal, where a single applica-
tion is the national standard. In settings using the multi-
day approach, families are responsible for continuing
daily CHX as part of cord care, and it is therefore an im-
perative that they receive information and training on
how to do this. Using our timestamped data, we learned
that CHX was applied very quickly after birth (median
time 2–4min), so it is likely that the mother is not aware
of the multi-step process of clamping, tying, cutting the
cord, and applying CHX. In the Nigerian study, it is pos-
sible that CHX application was outside the immediate
postpartum period, perhaps later during the first day (or
days after birth). The context of this study was in pri-
mary health care facilities, in contrast to our study in









t2:3 N (%) (CI) N (%) (CI) N (%) (CI) N% (CI)
t2:4 Exit-survey denominator 2826 livebirths 2253 livebirths 6748 livebirths
t2:5 All modes of birth combined
t2:6 Observer prevalence % 2582 (89.3) 2257 (97.9) 7112 (99.4) 96.6 (88.8,99.9)
t2:7 Survey-reported prevalence % 12 (0.4) 840 (37.3) 604 (9) 11..3 (0.3,34.6)
t2:8 Don’t know responses % 2189 (77.5) 1251 (55.5) 5355 (79.4) 71.5 (57.3,83.7)
t2:9 INCLUDES DON’T KNOW AS NO
t2:10 10 Cell Counts No Yes No
t2:11 % agreement 11.0 38.4 9.5 18.1 (5.5,35.9)
t2:12 Sensitivity ** ** 37.7 35.6, 39.7 ** ** 11.5 (0.3,34.9)
t2:13 Specificity ** ** 71.7 56.5, 84 ** ** 93.0 (66.0,100.0)
t2:14 EXCLUDES DON’T KNOW
t2:15 > 10 Cell Counts No No No
t2:16 % agreement 11.5 83.7 44.2 45.8 (10.0,84.3)
t2:17 Sensitivity 2.1 1.1, 3.6 84.7 82.3, 86.9 44.1 41.4, 46.8 39.7 2.7, 86.7
t2:18 Specificity 100 94.1, 100 23.5 6.8, 49.9 60 14.7, 94.7 70 3.2, 100
t2:19 Vaginal births
t2:20 Observer prevalence % 731 (96.3) 1290 (96.5) 6075 (99.4) 97.7 (94.4,99.6)
t2:21 Survey-reported prevalence % 4 (0.5) 601 (45.9) 536 (9.3) 13.6 (0.3,41.7)
t2:22 Don’t know responses % 565 (76.5) 629 (48.1) 4508 (78.6) 68.5 (47.9,85.9)
t2:23 INCLUDES DON’T KNOW AS NO
t2:24 > 10 Cell Counts No Yes No
t2:25 % agreement 4.2 47.8 9.9 17.4 (1.6,4.4)
t2:26 Sensitivity ** ** 46.9 44.1, 49.7 ** ** 13.9 (0.3,42.5)
t2:27 Specificity ** ** 72.7 57.2, 85 ** ** 91.6 (70.3100.0)
t2:28 EXCLUDES DON’T KNOW
t2:29 > 10 Cell Counts No No No
t2:30 % agreement 5.2 2.4, 9.6 88.2 85.6, 90.6 44.4 41.6, 47.3 44.4 7.5, 85.6
t2:31 Sensitivity 2.4 0.7, 6 89.8 87.2, 92 44.3 41.5, 47.2 42.8 5, 86.8
t2:32 Specificity 100 47.8, 100 25 7.3, 52.4 60 14.7, 94.7 63.2 11.5, 100
t2:33 Caesarean births
t2:34 Observer prevalence % 1850 (86.8) 967 (99.8) 1037 (99.2) 97.1 (85.6100.0)
t2:35 Survey-reported prevalence % 8 (0.4) 239 (25.3) 66 (6.7) 7.9 (0.0,27.9)
t2:36 Don’t know responses % 1624 (77.9) 622 (65.9) 823 (83.7) 76.4 (66.6,85.0)
t2:37 INCLUDES DON’T KNOW AS NO
t2:38 > 10 Cell Counts No No No
t2:39 % agreement 13.4 25.4 7.1 ** **
t2:40 Sensitivity ** ** ** ** ** ** ** **
t2:41 Specificity ** ** ** ** ** ** ** **
t2:42 EXCLUDES DON’T KNOW
t2:43 > 10 Cell counts No No No
t2:44 % agreement 13.9 10.9, 17.4 74.1 69, 78.8 42.3 34, 50.8 42.4 7.4, 82.7
t2:45 Sensitivity 2 0.9, 3.9 74.4 69.2, 79.1 42.3 34, 50.8 34.7 0, 88.4
t2:46 Specificity 100 93.6, 100 0 0, 97.5 – – 34.7 0, 88.4
t2:47 n = 12,379 observed livebirths, n = 11,827 livebirths with survey
t2:48 ** = result suppressed due to 10 or fewer count per column of two-by-two table
t2:49 7.1% Chlorhexidine solution applied to the umbilicus
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t3:3 N (%) (CI) N (%) (CI) N (%) (CI) N (%) (CI)
t3:4 Register-recorded denominator 2222 livebirths 1839 livebirths 6711 livebirths
t3:5 All modes of birth combined
t3:6 Observer prevalence % 2582 (89.3) 2257 (97.9) 7112 (99.4) 99.6 (88.8,99.9)
t3:7 Register-recorded prevalence % 2185 (98.3) 1796 (97.7) 5282 (78.7) 93.7 (76.4100.0)
t3:8 Not recorded 13 (0.6) 41 (2.2) 1394 (20.8) 5.4 (0.0,23.5)
t3:9 Not readable 0 (0) 0 (0) 4 (0.1) 0.0 (0.0,0.1)
t3:10 INCLUDES NOT RECORDED AND NOT READABLE AS NO
t3:11 > 10 Cell counts No No Yes
t3:12 % agreement 88.6 96.4 78.7 89.0 (76.4,97.1)
t3:13 Sensitivity ** ** ** ** 79 78, 80 93.8 (76.7100.0)
t3:14 Specificity ** ** ** ** 25 12.7, 41.2 8.8 (0.0,0.280)
t3:15 EXCLUDES NOT RECORDED AND NOT READABLE
t3:16 > 10 Cell counts No No No
t3:17 % agreement 88.6 96.4 98.9 95.5 (87.7,99.5)
t3:18 Sensitivity ** ** ** ** ** ** ** **
t3:19 Specificity ** ** ** ** ** ** ** **
t3:20 Vaginal births
t3:21 Observer prevalence % 731 (96.3) 1290 (96.5) 6075 (99.4) 97.7 (94.4,99.6)
t3:22 Register-recorded prevalence % 547 (97.9) 1073 (97.6) 4963 (84.3) 94.5 (82.2,99.9)
t3:23 Not recorded 7 (1.3) 25 (2.3) 894 (15.2) 4.9 (0.0,17.1)
t3:24 Not readable 0 (0) 0 (0) 3 (0.1) 0.0 (0.0,0.1)
t3:25 INCLUDES NOT RECORDED AND NOT READABLE AS NO
t3:26 > 10 Cell counts No No No
t3:27 % agreement 94.4 95.4 83.9 91.9 (82.1,98.0)
t3:28 Sensitivity ** ** ** ** ** ** ** **
t3:29 Specificity ** ** ** ** ** ** ** **
t3:30 EXCLUDES NOT RECORDED AND NOT READABLE
t3:31 > 10 Cell counts No No No
t3:32 % agreement 94.4 95.4 98.9 96.6 (92.5,99.1)
t3:33 Sensitivity ** ** ** ** ** ** ** **
t3:34 Specificity ** ** ** ** ** ** ** **
t3:35 Caesarean births
t3:36 Observer prevalence % 1850 (86.8) 967 (99.8) 1037 (99.2) 97.1 (85.6100.0)
t3:37 Register-recorded prevalence % 1638 (98.5) 723 (97.7) 318 (39) 85.5 (41.5100.0)
t3:38 Not recorded 6 (0.4) 16 (2.2) 495 (60.7) 12.9 (0.0,58.9)
t3:39 Not readable 0 (0) 0 (0) 1 (0.1) 0.0 (0.0,0.1)
t3:40 INCLUDES NOT RECORDED AND NOT READABLE AS NO
t3:41 > 10 Cell Counts No No No
t3:42 % agreement 86.6 ** 40.2 79.5 (43.2,99.3)
t3:43 Sensitivity ** ** ** ** ** ** ** **
t3:44 Specificity ** ** ** ** ** ** ** **


























































t3:46 N (%) (CI) N (%) (CI) N (%) (CI) N (%) (CI)
t3:47 EXCLUDES NOT RECORDED AND NOT READABLE
t3:48 > 10 Cell counts No No No
t3:49 % agreement 86.6 ** 99.1 95.7 (85.5100.0)
t3:50 Sensitivity ** ** ** ** ** ** ** **
t3:51 Specificity ** ** ** ** ** ** ** **
t3:52 n = 12,379 observed livebirths, n = 10,772 livebirths with register records
t3:53 ** = result suppressed due to 10 or fewer count per column of two-by-two table
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enced less separation from their newborn and thus been
able to see the CHX applied to the cord, or indeed may
have had to buy the CHX, or apply it personally. Alter-
natively, the variation between findings may be associ-
ated with the quality of health worker communication to
women. Exit survey findings suggest that health worker
communication needs improvement. Only 0.1–5.6% of
women reported that health workers told them why
CHX was used. This lack of awareness could be driven
by the proximity of events to birth, or a communication
failure between health workers and women.
The register data underestimated coverage in two
hospitals, performing poorly in one out of three. Register
design was found to be an important factor in the
accuracy of register-recorded coverage in this study; reg-
isters with specific columns outperformed those with
non-specific columns. However, in Bangladesh registers,
completion instructions meant it was not possible to
understand whether the intervention was deliberately
‘not given’ or was not recorded in the register for other
reasons (i.e. forgotten). Global guidance around register
design and indicator prioritisation is required, although
implementation and supportive supervision are alsoFig. 4 Facility register design and completion approaches for Chlorhexidin
livebirths, n = 10,772 register extracted livebirths. BD: Bangladesh; NP: Nepa
the registers were revised to standardised national EmONC register (Additio
documentation. Completeness calculations are “not possible” for Banglades
not done. Reference: Cut-off ranges adapted from WHO Data Quality Reviecrucial. Both hospitals in Bangladesh used the same
register design and instructions; however, they did not
perform equally. This may be related to different imple-
mentation strategies, as Azimpur staff received more de-
tailed training and ongoing support during register
rollout.
To date, validation research for tracking of cord care
practices has focused on population-based survey platforms
with no published evaluation regarding routine facility-
based measurement systems. This is a major gap, given as
many as 20 countries have a national policy for CHX that
includes facilities, and demonstrates the need for inclusion
of CHX as part of the WHO policy portal [22]. To our
knowledge, EN-BIRTH is the first study to assess validity of
CHX measurement from routine registers. Register design
was found to be an important factor in the accuracy of
register-recorded coverage in this study, registers with spe-
cific columns outperforming non-specific columns. How-
ever, the specific column in Azimpur was ticked when
CHX was not given and demonstrates the need for consist-
ent implementation, as well as design.
The increasing proportion of caesarean section births
worldwide has important implications for both care and
measurement. In one hospital in our study, women whoe application by site, EN-BIRTH study (n = 12,379). n = 12,379 observed
l. 7.1% Chlorhexidine solution applied to the umbilicus. In Bangladesh,
nal file 3), neither original facility register had any column for CHX
h registers as the design if for blank to mean intervention/practice is


























































f5:1 Fig. 5 Heat Map of Validity Ratios for Chlorhexidine cord application, EN-BIRTH study. BD: Bangladesh; NP: Nepal. Using cut off ranges adapted
f5:2 from WHO Data Quality Review, Module 2 “Desk review of data quality” [36]. Survey-reported to observed and register-recorded to observed.
f5:3 Observation n = 12,379 livebirths, register-recorded n = 10,002 livebirths and exit survey-reported n = 11,827 women with livebirths. 7.1%
f5:4 Chlorhexidine solution applied to the umbilicus
f5:5
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the other two sites there was very little difference
between vaginal and caesarean births. Newborns may be
cared for separately from their mothers after surgery,
and caesarean birth may exacerbate communication
gaps, especially if the woman had a general anaesthetic
or was unwell following surgery.
Interestingly, the high coverage and timely application
of CHX is in marked contrast to low coverage for
breastfeeding, where we found early initiation in the first
hour after birth to be just 19% averaged across all five
EN-BIRTH study sites [39]. Immediate newborn care is
part of essential newborn care and includes a number of
practices such as delayed cord clamping, breastfeeding,
and skin-to-skin contact, which are needed in the first
few minutes after birth. Pre-discharge interventions such
as eye care, vitamin K, newborn assessment, cord care
and immunisations are required; all should be imple-
mented with a focus on zero separation of women and
their newborns [15].
The immediate newborn care practice with the
strongest evidence base is early initiation of breastfeeding,
with high impact for reducing newborn morbidity and
mortality and contributing to health gains for the woman
[40–42]. CHX application does not yet have strong
evidence regarding facility-based application or for requir-
ing application within minutes. Under time pressure,
health workers might prioritise more easily achieved sim-
ple tasks, such as CHX application, over potentially time-consuming practices like assisting a mother and baby to
breastfeed. Other possibilities of why CHX was prioritised
at our study sites might include location of the CHX prod-
uct (which is only available on the labour ward, rather
than postnatal wards) or short admission stays where staff
take the opportunity immediately. There are important re-
search questions around the sequencing for immediate
and essential newborn care practices to optimise mortality
impact, especially with increasing time pressures on the
few midwives and other health care professionals.
Strengths and limitations
Strengths of this study include direct observation as the
gold standard, data collection by trained providers using
a custom-built tablet application with timestamping, the
large sample size and the multi-country, multi-site
contexts.
In terms of limitations, we note that validation results
are based on CEmONC hospitals, which might not be
generalizable to lower levels of care or for women who
birth at home or in private facilities. The presence of
researchers could have influenced how health workers
completed routine registers (Hawthorne effect) [43];
however, assessment of pre- and during study register
data quality is published separately and shows very little
difference over time [35].
Our survey questions were aligned to the current DHS
optional survey module questions regarding applications














f6:1 Fig. 6 Gap analysis for Chlorhexidine cord application coverage and quality, EN-BIRTH study (n = 12,379). Register-records n = 11,002 livebirths,
f6:2 and exit survey-report n = 11,827 women with livebirths. ‘Right time’ < 1 h was used here as the observation period is only during admission to
f6:3 labour and delivery wards. The current WHO recommendations advise that Chlorhexidine application should be completed within the first week
f6:4 of life. REF: World Health Organization. Recommendations on Postnatal care of the mother and newborn. WHO Library Cataloguing- Oct 2013.
f6:5 2014. 7.1% Chlorhexidine solution applied to the umbilicus
f6:6
Zaman et al. BMC Pregnancy and Childbirth _#####################_ Page 13 of 16women at exit interviews with a short recall period, ra-
ther than 3–5 years later, as is usual practice in
population-based surveys. Hence, our results could over-
estimate the validity of measurement for these survey
questions, since women may be more likely to accurately
report care in this shorter time interval (very soon after
birth). Conversely, many women reported “don’t know”and it is possible that for home births they may have
known more about what was done to their newborn’s
cord.
Research to improve measurement
Assessment for impact of CHX in facility settings is
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facility-based CHX cord application, further implemen-
tation research to explore how register design, filling
and use can improve data quality is required. Such re-
search should include assessment of health worker train-
ing and support. In addition to assessment of data flow
and data quality for this indicator’s inclusion in national
routine HMIS, evidence of feasibility and cost effective-
ness are also required [34]. For home births in high
mortality contexts, validation of survey questions regard-
ing women’s report of CHX application on day of birth
and afterwards is necessary. These studies could also ex-
plore use of visual prompts as used by DHS, such as a
picture of the commodity packaging most commonly
used in that context.
Conclusions
Routine register data performed better than exit survey-
report for measurement of CHX coverage in hospitals.
Routine registers are a promising source of data where
there is a national policy for facility-based CHX applica-
tion. Further research should assess the opportunity
costs in time for health workers to record, as well as util-
ity of the data if coverage is already extremely high. At-
tention to home births is essential to ensure the poorest
and most at-risk families are not omitted from coverage
measurement.
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pants and their care providers. All women were provided with a descrip-
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and offered the right to refuse, or withdraw consent at any time during
the study. Facility staff were identified before data collection began and
approached for recruitment and consent. No health worker refused par-
ticipation and all maintained the right to withdraw throughout the study.
This study was granted ethical approval by institutional review boards in
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Additional file 5. STROBE statement—checklist of items that should be
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An Explanation and Elaboration article discusses each checklist item and
gives methodological background and published examples of transparent
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bilical cord care practices, EN-BIRTH study (n = 12,379) n = 12,379 ob-
served livebirths, n = 11,827 livebirths with survey. Red colour: cell count
is < 5 in 2 × 2 table; blank (**) indicates cell could not construct as 2 × 2
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tices, EN-BIRTH study (n = 10,772). Red colour: cell count is < 5 in 2 × 2
table; blank (**) indicates cell could not construct as 2 × 2 table; Green
colour: cell count is ≥5 but < 10 in 2 × 2 table.
Additional file 9. Descriptive data for observer-assessed, register-
recorded, and survey-reported Chlorhexidine cord application, EN-BIRTH
study (n = 12,379 live births).
Abbreviations
BD: Bangladesh; CEmONC: Comprehensive emergency obstetric and
newborn care; CHX: 7.1% Chlorhexidine application to the umbilical cord;
CIFF: Children’s Investment Fund Foundation; DHS: Demographic Health
Surveys Program; EN-BIRTH: Every Newborn-Birth Indicators Research Tracking
in Hospitals study; HMIS: Health Management Information System;
icddr,b: International Centre for Diarrheal Disease Research, Bangladesh;
LMIC: Low- and Middle- Income Countries; LSHTM: London School of
Hygiene & Tropical Medicine; MCHTI: Maternal and Child Health Training
Institute, Azimpur, Bangladesh; MICS: Multiple Indicator Cluster Survey;
NP: Nepal; PRISM: Performance of Routine Information System Management;
UNICEF: United Nations International Children’s Emergency Fund;
WHO: World Health Organisation
Acknowledgements
Firstly, and most importantly, we thank the women, their families, the health
workers and data collectors. We credit the inspiration of the late Godfrey
Mbaruku. We thank Claudia DaSilva, Veronica Ulaya, Mohammad Raisul Islam,
Susheel Karki, Bhula Rai and Maria Cesay for their administrative support and
Sabrina Jabeen, Goutom Banik, Md. Shahidul Alam, Tamatun Islam Tanha and
Md. Moshiur Rahman for support during data collectors training.
We acknowledge the following groups for their guidance and support:
National Advisory Groups:
Bangladesh: Mohammad Shahidullah, Khaleda Islam, Md Jahurul Islam.
Nepal: Naresh P KC, Parashu Ram Shrestha, Tara Pokharel, Uwe Ewald.
Tanzania: Muhammad Bakari Kambi, Georgina Msemo, Asia Hussein, Talhiya
Yahya, Claud Kumalija, Eliakim Eliud, Mary Azayo, Mary Drake, Onest Kimaro.
EN-BIRTH validation collaborative group:
Bangladesh: Md. Ayub Ali, Bilkish Biswas, Rajib Haider, Md. Abu
Hasanuzzaman, Md. Amir Hossain, Ishrat Jahan, Rowshan Hosne Jahan,
Jasmin Khan, M A Mannan, Tapas Mazumder, Md. Hafizur Rahman, Md. Ziaul
Haque Shaikh, Aysha Siddika, Taslima Akter Sumi, Md. Taqbir Us Samad Talha.
Tanzania: Evelyne Assenga, Claudia Hanson, Edward Kija, Rodrick Kisenge,
Karim Manji, Fatuma Manzi, Namala Mkopi, Mwifadhi Mrisho, Andrea Pembe.
Nepal: Jagat Jeevan Ghimire, Regina Gurung, Elisha Joshi, Avinash K Sunny,
Naresh P. KC, Nisha Rana, Shree Krishna Shrestha, Dela Singh, Parashu Ram
Shrestha, Nishant Thakur,
LSHTM: Hannah Blencowe, Sarah G Moxon.
EN-BIRTH Expert Advisory Group: Agbessi Amouzou, Tariq Azim, Debra
Jackson, Theopista John Kabuteni, Matthews Mathai, Jean-Pierre Monet, Alli-
syn Moran, Pavani Ram, Barbara Rawlins, Jennifer Requejo, Johan Ivar Sæbø,
Florina Serbanescu, Lara Vaz.
About this supplement
This article has been published as part of BMC Pregnancy and Childbirth
Volume 20 Supplement 1, 2020: Every Newborn BIRTH multi-country study;
informing measurement of coverage and quality of maternal and newborn





































































































































Zaman et al. BMC Pregnancy and Childbirth _#####################_ Page 15 of 16bmcpregnancychildbirth.biomedcentral.com/articles/supplements/volume-2
0-supplement-1.
Authors’ contributions
The EN-BIRTH study was conceived by JEL, who acquired the funding and
led the overall design with support from HR. Each of the three country research
teams input to design of data collection tools and review processes, data
collection and quality management with technical coordination from HR, GGL,
and DB. The icddr,b team (notably AER, TT, TH, QSR, SA and SBZ) led the
development of the software application, data dashboards and database
development with VG and the LSHTM team. IHI (notably DS) coordinated work
on barriers and enablers for data collection and use, working closely with LTD.
QSR was the main lead for data management working closely with OB, KS and
LTD. For this paper, SBZ, ABS and HR led the analyses and first draft of manu-
script working closely with JEL and SA. All authors (AKC, KP, SA, NT, QSR, NS, RG,
TT, AER, PSC, BR, LTD) revised the manuscript and gave final approval of the ver-
sion to be published and agree to be accountable for the work. The EN-BIRTH
study group authors made contributions to the conception, design, data collec-
tion or analysis or interpretation of data. This paper is published with permission
from the Directors of Ifakara Health Institute, Muhimbili University of Health and
Allied Sciences, icddr,b and Golden Community. The author’s views are their
own, and not necessarily from any of the institutions they represent.
EN-BIRTH Study Group. Bangladesh: Qazi Sadeq-ur Rahman, Ahmed Ehsanur
Rahman, Tazeen Tahsina, Sojib Bin Zaman, Shafiqul Ameen, Tanvir Hossain,
Abu Bakkar Siddique, Aniqa Tasnim Hossain, Tapas Mazumder, Jasmin Khan,
Taqbir Us Samad Talha, Rajib Haider, Md. Hafizur Rahman, Anisuddin Ahmed,
Shams Arifeen. Nepal: Omkar Basnet, Avinash K Sunny, Nishant Thakur, Re-
gina Jurung, Anjani Kumar Jha, Bijay Jha, Ram Chandra Bastola, Rajendra Pau-
del, Asmita Paudel, Ashish KC. Tanzania: Nahya Salim, Donat Shamba,
Josephine Shabani, Kizito Shirima, Menna Narcis Tarimo, Godfrey Mbaruku
(deceased), Honorati Masanja. LSHTM: Louise T Day, Harriet Ruysen, Kimberly
Peven, Vladimir S Gordeev, Georgia R Gore-Langton, Dorothy Boggs, Stefanie
Kong, Angela Baschieri, Simon Cousens, Joy E Lawn.
Funding
The Children’s Investment Fund Foundation (CIFF) are the main funder of
the EN-BIRTH Study and funding is administered via The London School of
Hygiene & Tropical Medicine. The Swedish Research Council specifically
funded the Nepal site through Lifeline Nepal and Golden Community.
Publication of this manuscript has been funded by CIFF. CIFF attended the
study design workshop but had no role in data collection, analysis, data
interpretation, report writing or decision to submit for publication. The
corresponding author had full access to study data and final responsibility
for publication submission decision.
Availability of data and materials
The datasets generated during and/or analysed during the current study are
available on LSHTM Data Compass repository, https://datacompass.lshtm.ac.
uk/955/.
Ethics approval and consent to participate
This study was granted ethical approval by institutional review boards in all
operating counties in addition to the London School of Hygiene & Tropical
Medicine (Additional file 4).
Voluntary informed written consent was obtained from all observed
participants, their families for newborns, and respondents for the qualitative
interviews. Participants were assured of anonymity and confidentiality. All
women were provided with a description of the study procedures in their
preferred language at admission, and offered the right to refuse, or withdraw
consent at any time during the study. Facility staff were identified before
data collection began and no health worker refused to be observed whilst





The authors declare that they have no competing interests.Author details
1Maternal and Child Health Division, International Centre for Diarrhoeal
Disease Research, Bangladesh (icddr,b), 68 Shahid Tajuddin Ahmed Sarani,
Mohakhali, Dhaka, Bangladesh. 2The Maternal, Adolescent, Reproductive, &
Child, Health (MARCH) Centre, London School of Hygiene & Tropical
Medicine, London WC1E 7HT, UK. 3Department of Women’s and Children’s
Health, Uppsala University, Uppsala, Sweden. 4Florence Nightingale Faculty of
Nursing, Midwifery & Palliative Care, King’s College London, London, UK.
5Research Division, Golden Community, Lalitpur, Nepal. 6Department of
Paediatrics and Child Health, Muhimbili University of Health and Allied
Sciences, Dar es Salaam, Tanzania. 7Department of Health Systems, Impact
Evaluation and Policy, Ifakara Health Institute, Dar es Salaam, Tanzania.
8PATH, Seattle, WA, USA. 9Maternal and Child Survival Program, jhpiego,
Baltimore, MD, USA.
References
1. Blencowe H, Cousens S. Addressing the challenge of neonatal mortality.
Tropical Med Int Health. 2013;18(3):303–12.
2. UNICEF. The state of the World’s children 2019. Children, food and nutrition:
growing well in a changing world. New York: UNICEF; 2019. [https://www.
unicef.org/reports/state-of-worlds-children-2019]. Accessed 29 Sep 2020.
3. Liu L, Johnson HL, Cousens S, Perin J, Scott S, Lawn JE, Rudan I, Campbell H,
Cibulskis R, Li M. Global, regional, and national causes of child mortality: an
updated systematic analysis for 2010 with time trends since 2000. Lancet.
2012;379(9832):2151–61.
4. Moran AC, Kerber K, Sitrin D, Guenther T, Morrissey CS, Newby H, Fishel J,
Yoder PS, Hill Z, Lawn JE. Measuring coverage in MNCH: indicators for
global tracking of newborn care. PLoS Med. 2013;10(5):e1001415.
5. Mullany LC, Darmstadt GL, Tielsch JM. Role of antimicrobial applications to
the umbilical cord in neonates to prevent bacterial colonization and
infection: a review of the evidence. Pediatr Infect Dis J. 2003;22(11):996.
6. World Health Organisation: Recommendations on Postnatal care of the
mother and newborn. 2014 WHO library cataloguing- Oct 2013. [https://www.
who.int/maternal_child_adolescent/documents/postnatal-care-
recommendations/en/]. Accessed 29 Sep 2020.
7. PATH: From research to use: saving newborn lives with chlorhexidine for
umbilical cord care. 2017. [https://path.azureedge.net/media/documents/
DT_CHX_story_rpt.pdf]. Accessed 29 Sep 2020.
8. El Arifeen S, Mullany LC, Shah R, Mannan I, Rahman SM, Talukder MRR,
Begum N, Al-Kabir A, Darmstadt GL, Santosham M. The effect of cord
cleansing with chlorhexidine on neonatal mortality in rural Bangladesh: a
community-based, cluster-randomised trial. Lancet. 2012;379(9820):1022–8.
9. Mullany LC, Darmstadt GL, Khatry SK, Katz J, LeClerq SC, Shrestha S, Adhikari
R, Tielsch JM. Topical applications of chlorhexidine to the umbilical cord for
prevention of omphalitis and neonatal mortality in southern Nepal: a
community-based, cluster-randomised trial. Lancet. 2006;367(9514):910–8.
10. McClure EM, Goldenberg RL, Brandes N, Darmstadt GL, Wright LL, Group CW.
The use of chlorhexidine to reduce maternal and neonatal mortality and
morbidity in low-resource settings. Int J Gynecol Obstet. 2007;97(2):89–94.
11. Imdad A, Bautista RMM, Senen KAA, Uy MEV, Mantaring JB III, Bhutta ZA.
Umbilical cord antiseptics for preventing sepsis and death among
newborns. Cochrane Database Syst Rev. 2013;(5).
12. Soofi S, Cousens S, Imdad A, Bhutto N, Ali N, Bhutta ZA. Topical application
of chlorhexidine to neonatal umbilical cords for prevention of omphalitis
and neonatal mortality in a rural district of Pakistan: a community-based,
cluster-randomised trial. Lancet. 2012;379(9820):1029–36.
13. Mullany LC, Shah R, El Arifeen S, Mannan I, Winch PJ, Hill A, Darmstadt GL,
Baqui AH. Chlorhexidine cleansing of the umbilical cord and separation
time: a cluster-randomized trial. Pediatrics. 2013;131(4):708–15.
14. Mullany LC, Darmstadt GL, Khatry SK, LeClerq SC, Katz J, Tielsch JM. Impact
of umbilical cord cleansing with 4.0% chlorhexidine on time to cord
separation among newborns in southern Nepal: a cluster-randomized,
community-based trial. Pediatrics. 2006;118(5):1864–71.
15. World Health Organisation. WHO Recommendations on newborn health:
guidelines approved by the WHO guidelines review committee. Geneva:
WHO; 2017. [https://apps.who.int/iris/handle/10665/259269]. Accessed 29
Sep 2020.
16. Sazawal S, Dhingra U, Ali SM, Dutta A, Deb S, Ame SM, Mkasha MH, Yadav





































































































Zaman et al. BMC Pregnancy and Childbirth _#####################_ Page 16 of 16neonatal mortality in Pemba, Tanzania: a community-based randomised
controlled trial. Lancet Glob Health. 2016;4(11):e837–44.
17. Semrau KE, Herlihy J, Grogan C, Musokotwane K, Yeboah-Antwi K, Mbewe R,
Banda B, Mpamba C, Hamomba F, Pilingana P. Effectiveness of 4%
chlorhexidine umbilical cord care on neonatal mortality in Southern
Province, Zambia (ZamCAT): a cluster-randomised controlled trial. Lancet
Glob Health. 2016;4(11):e827–36.
18. Okomo U, Akpalu EN, Le Doare K, Roca A, Cousens S, Jarde A, Sharland M,
Kampmann B, Lawn JE. Aetiology of invasive bacterial infection and
antimicrobial resistance in neonates in sub-Saharan Africa: a systematic
review and meta-analysis in line with the STROBE-NI reporting guidelines.
Lancet Infect Dis. 2019;19(11):1219–34.
19. Mwananyanda L, Pierre C, Mwansa J, Cowden C, Localio AR, Kapasa ML,
Machona S, Musyani CL, Chilufya MM, Munanjala G. Preventing bloodstream
infections and death in Zambian neonates: impact of a low-cost infection
control bundle. Clin Infect Dis. 2019;69(8):1360–7.
20. Nankabirwa V, Tylleskär T, Tumuhamye J, Tumwine JK, Ndeezi G, Martines JC,
Sommerfelt H. Efficacy of umbilical cord cleansing with a single application of
4% chlorhexidine for the prevention of newborn infections in Uganda: study
protocol for a randomized controlled trial. Trials. 2017;18(1):322.
21. Mullany LC, El Arifeen S, Khatry SK, Katz J, Shah R, Baqui AH, Tielsch JM.
Impact of chlorhexidine cord cleansing on mortality, omphalitis, and cord
separation time among facility-born babies in Nepal and Bangladesh.
Pediatr Infect Dis J. 2017;36(10):1011.
22. Global chlorhexidine scale-up tracker: location of use [https://www.
healthynewbornnetwork.org/chlorhexidine-location/]. Accessed 28 Sep 2020.
23. Multiple indicator cluster surveys (MICS)6 tools [http://mics.unicef.org/
tools#survey-design]. Accessed 29 Sep 2020.
24. Demographic and Health Surverys (DHS) Model questionnaire - phase 7
[https://dhsprogram.com/publications/publication-dhsq7-dhs-
questionnaires-and-manuals.cfm]. Accessed 29 Sep 2020.
25. Bhattacharya AA, Allen E, Umar N, Usman AU, Felix H, Audu A, Schellenberg
JR, Marchant T. Monitoring childbirth care in primary health facilities: a
validity study in Gombe State, northeastern Nigeria. J Glob Health. 2019;9(2).
26. Hancioglu A, Arnold F. Measuring coverage in MNCH: tracking progress in
health for women and children using DHS and MICS household surveys.
PLoS Med. 2013;10(5):e1001391.
27. Blanc AK, Diaz C, McCarthy KJ, Berdichevsky K. Measuring progress in maternal
and newborn health care in Mexico: validating indicators of health system
contact and quality of care. BMC Pregnancy Childbirth. 2016;16(1):255.
28. Blanc AK, Warren C, McCarthy KJ, Kimani J, Ndwiga C, RamaRao S. Assessing
the validity of indicators of the quality of maternal and newborn health
care in Kenya. J Glob Health. 2016;6(1).
29. McCarthy KJ, Blanc AK, Warren CE, Kimani J, Mdawida B, Ndwidga C. Can
surveys of women accurately track indicators of maternal and newborn
care? A validity and reliability study in Kenya. J Glob Health. 2016;6(2).
30. Stanton CK, Rawlins B, Drake M, dos Anjos M, Cantor D, Chongo L, Chavane
L, da Luz VM, Ricca J. Measuring coverage in MNCH: testing the validity of
women's self-report of key maternal and newborn health interventions
during the peripartum period in Mozambique. PLoS One. 2013;8(5):e60694.
31. Strachan M, Drake M, Rawlins B, Dwivedi V, Levine B, Ly M, Ishola G:
Strengthening health management information systems for maternal and
child health: documenting MCHIP’s Contributions. Baltimore: Jhpiego , 17:2014.
32. Jolivet RR, Moran AC, O’Connor M, Chou D, Bhardwaj N, Newby H, Requejo
J, Schaaf M, Say L, Langer A. Ending preventable maternal mortality: phase II
of a multi-step process to develop a monitoring framework, 2016–2030.
BMC Pregnancy Childbirth. 2018;18(1):258.
33. World Health Organisation, UNICEF. Every newborn; an action plan to end
preventable deaths. Geneva: WHO; 2014. [https://www.who.int/maternal_
child_adolescent/newborns/every-newborn/en/]. Accessed 29 Sep 2020.
34. Day LT, Ruysen H, Gordeev VS, Gore-Langton GR, Boggs D, Cousens S,
Moxon SG, Blencowe H, Baschieri A, Rahman AE, et al. “Every Newborn-
BIRTH” protocol: observational study validating indicators for coverage and
quality of maternal and newborn health care in Bangladesh, Nepal and
Tanzania. J Glob Health. 2019;9(1).
35. Day LT, Rahman Q, Rahman A, Salim N, KC A, Ruysen H, Tahsina T, Masanja
H, Basnet O, Gordeev V, et al. Every newborn-BIRTH observational study to
test validity of newborn and maternal coverage measurement in routine
systems and surveys. Lancet Glob Health. [In Press].
36. World Health Organisation. Data quality review: a toolkit for facility data
quality assessment. Module 2: desk review of data quality. Geneva: WorldHealth Organisation; 2017. [https://apps.who.int/iris/handle/10665/259225].
Accessed 28 Sep 2020.
37. Shamba D, Day LT, Zaman SB, Khan J, Talha T, Rahman M, Kayastha A,
Thakur N, Tarimo M, Singh N et al: Barriers and enablers to routine data
collection and use: EN-BIRTH multi-country study informing routine
measurement of coverage and quality BMC Pregnancy Childbirth [In press].




39. Tahsina T, Hossain AT, Ruysen H, Rahman AE, Day LT, Peven K, Rahman QS-U,
Khan J, Shabani J, KC A, et al. Immediate newborn care and breastfeeding
practices: EN-BIRTH multi-country study informing routine measurement of
coverage and quality. BMC Pregnancy Childbirth. 2019; In press.
40. Khan J, Vesel L, Bahl R, Martines JC. Timing of breastfeeding initiation and
exclusivity of breastfeeding during the first month of life: effects on
neonatal mortality and morbidity—a systematic review and meta-analysis.
Matern Child Health J. 2015;19(3):468–79.
41. NEOVITA Study Group. Timing of initiation, patterns of breastfeeding, and
infant survival: prospective analysis of pooled data from three randomised
trials. Lancet Glob Health. 2016;4(4):e266–75.
42. Debes AK, Kohli A, Walker N, Edmond K, Mullany LC. Time to initiation of
breastfeeding and neonatal mortality and morbidity: a systematic review.
BMC Public Health. 2013;13(3):S19.
43. Campbell JP, Maxey VA, Watson WA. Hawthorne effect: implications for
prehospital research. Ann Emerg Med. 1995;26(5):590–4.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
